Clinical Trial: Blood Biomarkers in Pediatric Kidney Transplant Recipients
Study Status: Completed
Recruit Status: RECRUITING
Condition: Rejection of Kidney Allograft
Study Type: OBSERVATIONAL
Official Title: Use of Blood Gene Expression Profile and Donor-derived Cell-free DNA to Monitor Response to Treatment After Biopsy-proven Acute Rejection in Pediatric Kidney Transplant Recipients
Brief Summary:
The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection.The study hypothesizes that blood gene expression profile and donor-derived cell-free DNA biomarkers (omnigraf) can be used to predict acute rejection and monitor its response to treatment.
Read more